1-13390485-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001099851.3(PRAMEF17):ā€‹c.432C>Gā€‹(p.His144Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000285 in 1,611,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H144Y) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00018 ( 0 hom., cov: 32)
Exomes š‘“: 0.00030 ( 0 hom. )

Consequence

PRAMEF17
NM_001099851.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -2.98
Variant links:
Genes affected
PRAMEF17 (HGNC:29485): (PRAME family member 17) Predicted to be involved in several processes, including negative regulation of apoptotic process; negative regulation of transcription, DNA-templated; and positive regulation of cell population proliferation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0121457875).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PRAMEF17NM_001099851.3 linkuse as main transcriptc.432C>G p.His144Gln missense_variant 2/3 ENST00000376098.4 NP_001093321.1 Q5VTA0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PRAMEF17ENST00000376098.4 linkuse as main transcriptc.432C>G p.His144Gln missense_variant 2/31 NM_001099851.3 ENSP00000365266.3 Q5VTA0

Frequencies

GnomAD3 genomes
AF:
0.000177
AC:
27
AN:
152134
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000368
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000174
AC:
43
AN:
246476
Hom.:
5
AF XY:
0.000157
AC XY:
21
AN XY:
133946
show subpopulations
Gnomad AFR exome
AF:
0.000137
Gnomad AMR exome
AF:
0.0000581
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000315
Gnomad OTH exome
AF:
0.000667
GnomAD4 exome
AF:
0.000297
AC:
433
AN:
1459710
Hom.:
0
Cov.:
34
AF XY:
0.000262
AC XY:
190
AN XY:
726166
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000373
Gnomad4 OTH exome
AF:
0.000216
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152252
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000368
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000131
Hom.:
1
Bravo
AF:
0.000196
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000471
AC:
4
ExAC
AF:
0.000142
AC:
17

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 12, 2023The c.432C>G (p.H144Q) alteration is located in exon 2 (coding exon 2) of the PRAMEF17 gene. This alteration results from a C to G substitution at nucleotide position 432, causing the histidine (H) at amino acid position 144 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.0050
DANN
Benign
0.25
DEOGEN2
Benign
0.0030
T
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.00045
N
LIST_S2
Benign
0.020
T
M_CAP
Benign
0.0013
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N
PrimateAI
Benign
0.46
T
PROVEAN
Benign
0.34
N
REVEL
Benign
0.0080
Sift
Benign
1.0
T
Sift4G
Benign
0.71
T
Polyphen
0.068
B
Vest4
0.12
MutPred
0.38
Gain of methylation at K148 (P = 0.0726);
MVP
0.043
MPC
1.9
ClinPred
0.012
T
GERP RS
-2.2
Varity_R
0.032
gMVP
0.058

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199811283; hg19: chr1-13716945; API